These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 27454390)
1. Intravenous Immunoglobulin Therapy in a Patient With Anti-Myelin Oligodendrocyte Glycoprotein-Seropositive Neuromyelitis Optica. Domingo-Santos Á; Sepúlveda M; Matarazzo M; Calleja-Castaño P; Ramos-González A; Saiz A; Benito-León J Clin Neuropharmacol; 2016; 39(6):332-334. PubMed ID: 27454390 [No Abstract] [Full Text] [Related]
2. Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review. Cellina M; Fetoni V; Ciocca M; Pirovano M; Oliva G Neuroradiol J; 2018 Feb; 31(1):69-82. PubMed ID: 28379073 [TBL] [Abstract][Full Text] [Related]
3. Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody. Ikeda K; Kiyota N; Kuroda H; Sato DK; Nishiyama S; Takahashi T; Misu T; Nakashima I; Fujihara K; Aoki M Mult Scler; 2015 Apr; 21(5):656-9. PubMed ID: 25257613 [TBL] [Abstract][Full Text] [Related]
4. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621 [TBL] [Abstract][Full Text] [Related]
5. Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica. Woodhall M; Çoban A; Waters P; Ekizoğlu E; Kürtüncü M; Shugaiv E; Türkoğlu R; Akman-Demir G; Eraksoy M; Vincent A; Tüzün E J Neurol Sci; 2013 Dec; 335(1-2):221-3. PubMed ID: 24045088 [TBL] [Abstract][Full Text] [Related]
6. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Neuromyelitis Optica Spectrum Disorder in a 6-Year-Old Boy. Kamawal A; Hoerning S; Galiano M; Rompel O; Trollmann R Klin Padiatr; 2019 Jul; 231(4):220-223. PubMed ID: 31064015 [No Abstract] [Full Text] [Related]
7. Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity. Xu Y; Zhang Y; Liu CY; Peng B; Wang JM; Zhang XJ; Li HF; Cui LY Chin Med J (Engl); 2012 Sep; 125(18):3207-10. PubMed ID: 22964310 [TBL] [Abstract][Full Text] [Related]
8. Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies. Hino-Fukuyo N; Haginoya K; Nakashima I; Sato DK; Takahashi T; Misu T; Fujihara K; Hirose M; Kakisaka Y; Uematsu M; Kobayashi T; Kure S Brain Dev; 2015 Oct; 37(9):849-52. PubMed ID: 25748628 [TBL] [Abstract][Full Text] [Related]
9. NMOSD with anti-MOG antibodies following anti-TNFα therapy: A case report. Lommers E; Depierreux F; Hansen I; Dive D; Maquet P Mult Scler Relat Disord; 2018 Nov; 26():37-39. PubMed ID: 30219743 [TBL] [Abstract][Full Text] [Related]
10. Comment on severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody. Arrambide G; Tur C; Montalban X Mult Scler; 2015 Apr; 21(5):660-1. PubMed ID: 25662350 [No Abstract] [Full Text] [Related]
11. Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies. Gao J; Pan W; Zhang H JAMA Neurol; 2014 Jul; 71(7):923-4. PubMed ID: 25023552 [No Abstract] [Full Text] [Related]
12. Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply. Kitley J; Waters P; Vincent A; Palace J JAMA Neurol; 2014 Jul; 71(7):924. PubMed ID: 25023554 [No Abstract] [Full Text] [Related]
13. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068 [TBL] [Abstract][Full Text] [Related]
14. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827 [TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands. van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750 [TBL] [Abstract][Full Text] [Related]
17. Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy. Thulasirajah S; Pohl D; Davila-Acosta J; Venkateswaran S Neuropediatrics; 2016 Aug; 47(4):245-52. PubMed ID: 27128728 [TBL] [Abstract][Full Text] [Related]
18. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases. Spadaro M; Meinl E Methods Mol Biol; 2016; 1304():99-104. PubMed ID: 25814289 [TBL] [Abstract][Full Text] [Related]
19. Use of ganglion cell layer analysis for diagnosing anti-glycoprotein neuromyelitis optica of oligodendrocyte myelin. Cerveró A; Sedano-Tous MJ; Madera J; López-de-Eguileta A; Casado A Arch Soc Esp Oftalmol (Engl Ed); 2020 Mar; 95(3):146-149. PubMed ID: 31980323 [TBL] [Abstract][Full Text] [Related]
20. An interesting PRESentation of NMO. Klenofsky B; Youn C; Walters H; Navis A; Boniece I Mult Scler Relat Disord; 2018 Oct; 25():163-164. PubMed ID: 30081316 [No Abstract] [Full Text] [Related] [Next] [New Search]